Viridian Therapeutics, Inc. company logo
Viridian Therapeutics, Inc. logo

Viridian Therapeutics, Inc. (VRDN) Selling, General & Administrative Expenses

Annual SG&A

$61.08M$33.92M-35.70%

Summary

Current Value
As of today, VRDN annual SG&A is $61.08M, down -35.70% on
Historical Performance
VRDN annual SG&A is up +136.71% over the past 3 years, and up +424.50% over the past 5 years
All-Time High Comparison
VRDN annual SG&A is currently -35.70% below its historical high of $95.00M set on
3-Year Low Comparison
VRDN annual SG&A is +73.62% above its 3-year low of $35.18M reached on an earlier date
Sector Comparison
VRDN annual SG&A is higher than 77.07% of companies in Healthcare sector

SG&A Chart

Add series to chart
Add series to chart1/6
Series
SUGGESTED SERIES

Performance

VRDN Performance
MetricDateValue1Y3Y5Y15Y
Annual SG&A$61.08M-35.7%+136.7%+424.5%+1343.0%
Quarterly SG&A$0.00-100.0%-100.0%-100.0%-100.0%
TTM SG&A-$4.48B-5807.9%-10000.0%-10000.0%-10000.0%
Price$30.57+46.2%+11.3%+66.1%
Annual Operating Expenses$299.34M+17.5%+262.0%+544.6%+6613.7%
Annual Operating Profit-$299.04M-17.5%-275.1%-612.3%-9562.8%
Annual D&A$540.00K+3.5%+350.0%+87.5%+274.2%
Annual Revenue$302.00K-3.8%-89.8%-93.2%-93.2%

SG&A Highs

VRDN Annual SG&A Highs Comparison
PeriodHighDateCurrent
3Y$95.00M-35.7%
5Y$95.00M-35.7%
All$95.00M-35.7%

SG&A Lows

VRDN Annual SG&A Lows Comparison
PeriodLowDateCurrent
3Y$35.18MN/A+73.6%
5Y$13.27MN/A+360.5%
All$1.76M+3370.6%

SG&A History

YearValueChange
$61.08M-35.7%
$95.00M+170.0%
$35.18M+36.3%
$25.81M+94.5%
$13.27M+13.9%
$11.65M+5.4%
YearValueChange
$11.05M+1.3%
$10.91M+14.0%
$9.58M-6.6%
$10.25M+35.3%
$7.57M-

FAQ

  • What is the current annual SG&A of VRDN?

    As of today, VRDN annual SG&A is $61.08M

  • What is 1-year change in VRDN annual SG&A?

    VRDN annual SG&A is down -35.70% year-over-year

  • What is 3-year change in VRDN annual SG&A?

    VRDN annual SG&A is up +136.71% over the past 3 years

  • How far is VRDN annual SG&A from its all-time high?

    VRDN annual SG&A is currently -35.70% below its historical high of $95.00M set on December 31, 2023

  • How does VRDN annual SG&A rank versus sector peers?

    VRDN annual SG&A is higher than 77.07% of companies in Healthcare sector

  • When is VRDN next annual earnings release?

    The next annual earnings release for VRDN is on

Selling, General & Administrative Expenses Formula

SG&A = − R&D

Data Sources & References

  1. VRDN Official Website www.viridiantherapeutics.com
  2. Most Recent Quarterly Report (10-Q) www.sec.gov/Archives/edgar/data/1590750/000159075025000020/0001590750-25-000020-index.htm
  3. Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1590750/000159075025000004/0001590750-25-000004-index.htm
  4. VRDN Profile on Yahoo Finance finance.yahoo.com/quote/VRDN
  5. VRDN Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/vrdn